NCT02468128View on ClinicalTrials.gov

A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Analgesia DisorderPain
Interventions
DRUG

Sebacoyl Dinalbuphine Ester

Intramuscular injection 2mL/vial (75mg/mL)

DRUG

Placebo

Sebacoyl Dinalbuphine Ester injection placebo, 2mL/vial

Trial Locations (6)

114

Tri-Service General Hospital, Taipei

244

Chang Gung Memorial Hospital at Linkuo, Linkuo

20401

Chang Gung Memorial Hospital at Keelung, Keelung

40764

Cheng Ching General Hospital, Taichung

61363

Chang Gung Memorial Hospital at Chiayi, Putzu City

88301

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung City

Sponsors
All Listed Sponsors
lead

Lumosa Therapeutics Co., Ltd.

INDUSTRY